One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Why Choose Microarrays over Other Technologies?November 10, 2023Microarrays are becoming an increasingly popular choice for biologists and researchers worldwide. With the help of advanced technology, these arrays provide a cost-effective and efficient way to analy...view
What Is The Normal Metabolic Testing?March 11, 2024In the rapidly evolving landscape of healthcare diagnostics, metabolic testing has emerged as a cornerstone for understanding individual health profiles and tailoring interventions accordingly. Capita...view